Zoetis Inc (ZTS) Stock Price Today
Aura AI Summary
Key Stats
- $30.71BMARKET_CAP
- -VOLUME
- HealthSECTOR
- $159.18FIFTY_TWO_WEEK_HIGH
- $71.91FIFTY_TWO_WEEK_LOW
- -TYPICAL_HOLD_TIME
- $38.01BENTERPRISE_VALUE
- 2.83%DIVIDEND_YIELD
- -TRADING_ACTIVITY
Track Zoetis Inc (ZTS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Zoetis Inc has traded between a low of $71.91 and a high of $159.18, highlighting its annual price range. Buy and sell Zoetis Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Most Recent News
Tariff uncertainty fuels volatility as Dow eyes 55,000 and S&P 500 targets 8,000.
The US stock market shows resilience amid tariff uncertainties and mixed labor data. The Dow Jones benefits from a rotation into value and cyclical stocks, supporting a bullish outlook toward 55,000. Meanwhile, the S&P 500 faces pressure from weak me...

Imugene reports second complete response in Phase 1b trial for aggressive lymphoma treatment
Imugene Ltd announced a second complete response in its Phase 1b azer-cel trial targeting patients with mantle cell lymphoma (MCL) who had failed prior BTKi therapy. The patient showed complete tumor shrinkage by Day 28, earlier than expected, highli...

Valterra Platinum seen as undervalued with strong 2025 EBITDA growth and strategic refining edge.
Valterra Platinum is considered undervalued because it is viewed more as a strategic, integrated platinum group metals (PGM) platform rather than a typical cyclical miner. Its 2025 adjusted EBITDA is projected to rise 68% to R33.4 billion, with margi...
